Peabody Energy Corp, (NYSE:BTU) said on Monday that it plans to issue $1 billion in seven-year notes to refinance debt and for other general corporate purposes, making it the latest company to tap bond markets to revamp its balance sheet amid historically low interest rates. On Monday shares of Peabody Energy Corp. (NYSE:BTU) closed at $7.49. Company’s sales growth for last 5 years was 3.00% and EPS growth for next 5 years is recorded as 12.08%.
NXP Semiconductors N.V (NASDAQ:NXPI) has entered into a definitive agreement to acquire Austin, Texas based Freescale Semiconductor for a total value of $16.7 billion including debt. NXP Semiconductors NV (NASDAQ:NXPI) in last trading activity moved up 17.27% to close at $99.56. Company weekly performance is 17.82% while its quarterly performance stands at 27.89%. NXP Semiconductors NV (NASDAQ:NXPI) is 15.10% away from its 52 week high.
Scorpio Tankers (NYSE: STNG) declared a quarterly dividend of $0.12 per share, or $0.48 annualized. The dividend will be payable on March 30, 2015, to stockholders of record on March 13, 2015, with an ex-dividend date of March 11, 2015.On last trading day Scorpio Tankers Inc. (NYSE:STNG) advanced 1.73% to close at $8.81. Its volatility for the week is 3.23% while volatility for the month is 3.33%. STNG’s sales growth for past 5 years was 39.50% and its EPS growth for past 5 years was -45.00%. Scorpio Tankers Inc. (NYSE:STNG) monthly performance is 7.44%.
On 26 February, AGNITY, and Radisys® Corporation (NASDAQ: RSYS), said that they have introduced a virtualized interactive communications service platform for broadband mobile networks.RadiSys Corporation (NASDAQ:RSYS) has 1.20% insider ownership while its institutional ownership stands at 75.90%. In last trading activity company’s stock closed at $2.38.
On 27 February, Pharmacyclics, Inc. (NASDAQ:PCYC) announced that longer-term toxicology studies for its newly developed Bruton’s tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed. On last trading day Pharmacyclics Inc. (NASDAQ:PCYC) advanced 2.48% to close at $221.29. Its volatility for the week is 7.88% while volatility for the month is 5.51%. PCYC’s sales growth for past 5 years was 139.30% and its EPS growth for past 5 years was 40.90%. Pharmacyclics Inc. (NASDAQ:PCYC) monthly performance is 32.14%.